enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Amgen (AMGN) to Report Q3 Earnings: What's in the Cards? - AOL

    www.aol.com/news/amgen-amgn-report-q3-earnings...

    Volume growth of Amgen's (AMGN) key drugs like Prolia, Kyprolis, Repatha and others and biosimilars portfolio is expected to have been partially offset by biosimilar/generic competition for mature ...

  3. Top Analyst Reports for Amgen, TOTAL & Intuit - AOL

    www.aol.com/news/top-analyst-reports-amgen-total...

    For premium support please call: 800-290-4726 more ways to reach us

  4. Top Analyst Reports for Walmart, Amgen and Honda - AOL

    www.aol.com/news/top-analyst-reports-walmart...

    For premium support please call: 800-290-4726 more ways to reach us

  5. Top Research Reports for Amazon, Amgen & TOTAL - AOL

    www.aol.com/news/top-research-reports-amazon...

    Top Research Reports for Amazon, Amgen & TOTAL

  6. Amgen (AMGN) to Report Q3 Earnings: What's in the Cards? - AOL

    www.aol.com/news/amgen-amgn-report-q3-earnings...

    Volume growth from Amgen's (AMGN) key drugs like Prolia, Xgeva, Repatha and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.

  7. Top Research Reports for Amgen, BHP, Altria & Others

    www.aol.com/news/top-research-reports-amgen-bhp...

    For premium support please call: 800-290-4726 more ways to reach us

  8. Top Research Reports for Amgen, Altria Group & Uber - AOL

    www.aol.com/news/top-research-reports-amgen...

    Today's Research Daily features new research reports on 16 major stocks, including Amgen Inc. (AMGN), Altria Group, Inc. (MO), and Uber Technologies, Inc. (UBER).

  9. Amgen's peek at its GLP-1 drug trial results heightens ... - AOL

    www.aol.com/finance/amgens-peek-glp-1-drug...

    Amgen's positive trial results update on its GLP-1 injectable for obesity, MariTide, sent its ... Lilly recorded a total of $2 billion from its GLP-1 products in 2023, while Novo Nordisk pocketed ...